Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction.

Hansen, Malene K; Olesen, Kevin K W; Gyldenkerne, Christine; Thrane, Pernille G; Stødkilde-Jørgensen, Nina; Mortensen, Martin B; Maeng, Michael

Hansen, Malene K; Olesen, Kevin K W; Gyldenkerne, Christine; Thrane, Pernille G; Stødkilde-Jørgensen, Nina; Mortensen, Martin B; Maeng, Michael.

Affiliation

Hansen MK; Aarhus University Hospital, Aarhus, Denmark; Aarhus University, Aarhus, Denmark.
Olesen KKW; Aarhus University Hospital, Aarhus, Denmark.
Gyldenkerne C; Aarhus University Hospital, Aarhus, Denmark; Aarhus University, Aarhus, Denmark.
Thrane PG; Aarhus University Hospital, Aarhus, Denmark; Aarhus University, Aarhus, Denmark.
Stødkilde-Jørgensen N; Aarhus University Hospital, Aarhus, Denmark; Aarhus University, Aarhus, Denmark.
Mortensen MB; Aarhus University Hospital, Aarhus, Denmark; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Maeng M; Aarhus University Hospital, Aarhus, Denmark; Aarhus University, Aarhus, Denmark. Electronic address: michael.maeng@clin.au.dk.

J Am Coll Cardiol ; 83(9): 956-958, 2024 Mar 05.

Article de En | MEDLINE | ID: mdl-38418010

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Infarctus du myocarde Limites: Humans Langue: En Journal: J Am Coll Cardiol Année: 2024 Type de document: Article Pays d'affiliation: Danemark

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google